Improvado Improvado
Book a demo

Agentic marketing intelligence for regulated industries

Connect 1,000+ sources — including HCP platforms other tools don't support — inside a HIPAA-aware intelligence layer that acts, not just reports. No PHI in the pipeline. BAA-eligible. Average deploy: 14 days.

1,000+ data sourcesAny warehouse or BI tool
Marketing OS DTC + HCP COMPLIANT
can i finally see dtc and hcp spend in one model?
Google Ads one normalized model · no PHI · BAA-eligible

Yes — patient and professional outreach, normalized side by side:

spend model composition · Q3
HCP media 44%
Google Ads DTC paid 38%
CRM + email 12%
Events 6%
harmonized across 1,000+ sources, HCP publishers included
Enterprise-grade security
SOC 2 Type II — AICPA certified HIPAA compliant
What's possible

What pharma and biotech teams unlock

Results from pharmaceutical and biotech brands on Improvado

Recovered monthly
60–150h
Hours returned from manual operations through automatic taxonomy enforcement.
Average deployment
14 days
Typical time to live data across paid media, HCP platforms, and CRM.
Sources connected
1,000+
Including Doximity, DeepIntent, Medscape, Phreesia, and SFTP publishers.
How it works

Three steps from fragmented data to marketing intelligence

Most pharma tools are built for IT. Improvado is built for marketers who need HCP data, compliance, and attribution in one place.

Book a demo

Connect — HCP platforms and standard channels

Native connectors for Doximity, DeepIntent, Medscape, Phreesia, and Epocrates alongside Google Ads, Meta, DV360, LinkedIn, Salesforce Health Cloud — no custom engineering for specialty publishers.

Unify — HIPAA-aware, BAA-eligible ETL

MDG taxonomy enforcement, consent signal tracking, no PHI storage, SOC 2 Type II certification, and EU data residency — all documentation packages ready for legal team sign-off and procurement timelines.

Act — cross-channel attribution, anomaly alerts, CMO views

Privacy-safe marketing mix modeling, anomaly alerts before board-level issues emerge, weekly digest automation per brand or therapeutic area, and a CMO executive view combining DTC and HCP in one model.

Why pharma and biotech teams choose Improvado

Native HCP platform connectors

Pre-built connections to Doximity, Medscape, PulsePoint, DeepIntent, Epocrates, and Phreesia — no custom engineering for specialty sources.

HIPAA-aware architecture

No PHI storage. BAA-eligible processing. Separates marketing signals from health identifiers. EU data residency available on request.

Unified DTC + HCP attribution

Patient and professional outreach combined in a single normalized model — eliminating siloed reporting across DTC and HCP budgets.

Automatic taxonomy enforcement

MDG enforces naming conventions across all teams, agencies, and publishers in real time — no manual audits, no retroactive cleanup.

The difference

Purpose-built for regulated marketing — not adapted from it

Datorama, Fivetran, and Funnel weren't built for HIPAA. In-house engineering spends 40%+ of its time on maintenance. Here's what purpose-built looks like.

Without Improvado
  • 15–25 disconnected sources with no unified schema across HCP and paid media
  • No native connectors for Doximity, DeepIntent, Medscape, or Phreesia
  • GA4 lacks BAA — inherited pixels expose PHI risk across the analytics stack
  • Taxonomy chaos across 15+ platforms destroys cross-channel attribution
  • 3–6 month procurement delays for platforms not built for pharma compliance
With Improvado
  • 1,000+ sources including all major HCP platforms in a single unified model
  • Native connectors for specialty publishers — no SFTP workarounds required
  • HIPAA-aware ETL with BAA-eligible processing and full pixel audit trail
  • MDG taxonomy enforcement across all teams, agencies, and publishers in real time
  • SOC 2 Type II documentation ready to support pharmaceutical procurement cycles

See HIPAA-aware marketing intelligence with your data

Our pharma team will audit your campaign taxonomy, connect your top 3 sources in 24 hours, and show you a live unified view — no commitment required.

Book a demo
A global pharmaceutical enterprise
Proven results

Unifying HCP platforms (Epocrates, DeepIntent, specialty publishers) alongside standard ad channels required 60–150 hours of manual operations each month and had no consistent taxonomy across global teams.

60–150h recovered monthly from manual operations
Automatic taxonomy enforcement across global teams
Unified HCP and paid media in one normalized model
How Improvado helped
  • Connected Epocrates, DeepIntent, and specialty publishers alongside Google and Meta
  • Applied MDG taxonomy automatically across all teams and agency partners
  • Eliminated manual data engineering overhead without additional headcount
A global biotech company
Proven results

Dozens of specialty publisher integrations via SFTP required custom pipelines with zero-error tolerance — consuming most of the data engineering team's available bandwidth.

Zero-error ETL with automated validation at every step
Eliminated data engineering overhead for SFTP ingestion
Automated normalization across all specialty publishers
How Improvado helped
  • Replaced custom SFTP pipelines with pre-built flat file ingestion connectors
  • Applied automated validation and normalization at every transformation step
  • Freed data engineering team to focus on analysis rather than pipeline maintenance

HIPAA-aware marketing intelligence, built for regulated industries

No commitment. HIPAA-aware architecture. Average deploy: 14 days.